ライフサイエンスコーパス: pancreatic head

1 ents had a large dominant tumor (4 cm in the pancreatic head).

2 d by SRS and the majority are located in the pancreatic head.

3 he bile duct at the porta hepatis and in the pancreatic head.

4 severe chronic pancreatitis centered in the pancreatic head.

5 atients with clinical stage I or II resected pancreatic head adenocarcinoma.

6 it compared with UR in early-stage, resected pancreatic head adenocarcinoma.

7 d the presence of a 1.2 x 2 cm lesion in the pancreatic head and a liver metastatis.

8 Histopathological examination of the pancreatic head and corpus at day 7 revealed less edema

9 It is recommended for continued use in pancreatic head and gallbladder cancers but not in ampul

10 eatic MCNs for which risks include male sex, pancreatic head and neck location, larger MCN, solid com

11 er pancreaticoduodenectomy for tumors of the pancreatic head and periampullary region.

12 of complex surgical procedures involving the pancreatic head and root of mesentery.

13 Diagnostic categories were cancer of the pancreatic head and uncinate process, cancer of the body

14 d MR imaging: Most are small, located in the pancreatic head, and enhance homogeneously.

15 Local resection of the pancreatic head appears to offer best outcomes and lowes

16 denum from the uncinate process and adjacent pancreatic head areas or the entire gland.

17 PDFF was assessed in the pancreatic head, body, and tail.

18 benefit compared with standard resection in pancreatic head cancer.

19 a were analyzed for patients with stage I/II pancreatic head cancers treated from 2004 to 2009.

20 cholera toxin B (CTB) was injected into the pancreatic head (CTB-488) and tail (CTB-555) of adult ma

21 ng management strategies in a patient with a pancreatic head cyst radiographically suggestive of BD-I

22 atients with localized adenocarcinoma of the pancreatic head deemed resectable on the basis of radiog

23 argin status for survival after resection of pancreatic-head ductal adenocarcinoma.

24 y curative therapy for adenocarcinoma of the pancreatic head during a 5-year period.

25 Fifteen (52%) tumors were located in the pancreatic head; eight (28%), in the tail; and six (21%)

26 y or a Frey-procedure in case of an enlarged pancreatic head (>/=4 cm).

27 sectable at presentation than lesions in the pancreatic head, have similar postresection survival.

28 adenocarcinoma and a low-density mass in the pancreatic head identified by computed tomography (CT) r

29 The tumor was located at the pancreatic head in 7 patients and the body/tail in 26 pa

30 The tumor was located at the pancreatic head in 7 patients and the body/tail in 26 pa

31 the authors and others for resection of the pancreatic head in this disease, but distal pancreatecto

32 severe chronic pancreatitis centered in the pancreatic head, intractable abdominal pain, and a main

33 Surgical procedures for tumors of the pancreatic head involve time-consuming manual dissection

34 ere black, were on Medicare or Medicaid, had pancreatic head lesions, earned lower annual incomes, or

35 mm (average 12.8 mm) and were located in the pancreatic head (n=7), body (n=2), tail (n=3) and uncina

36 Local resection or excavation of the pancreatic head offers the advantage of lowest cost and

37 l SMV, cancers in the inferior aspect of the pancreatic head or root of mesentery (mid gut carcinoid)

38 tudy group] vs 2.89 +/- 0.33 [control group, pancreatic head]; p = 0.03; 2.2 +/- 0.92 [study group] v

39 Macroscopic cancers of the pancreatic head presented regularly with common bile duc

40 was significantly greater innervation of the pancreatic head relative to the tail.

41 found to be better after duodenum-preserving pancreatic head resection (DPPHR) than after partial pan

42 Pancreatic head resection in selected patients with chro

43 thout duct drainage, and duodenum-preserving pancreatic head resection offer outcomes as effective as

44 Patients undergoing pancreatic head resection with pancreaticojejunal anasto

45 ollowing types of resections were performed: pancreatic head resections [n = 77 (75%)], tail resectio

46 PJ], 29 distal pancreatectomies [DP], and 46 pancreatic head resections [PHR; 14 performed after fail

47 eaticoduodenectomy for adenocarcinoma of the pancreatic head resulted in similar treatment toxicity,

48 Patients with pancreatic head tumors (n = 388) had a median survival o

49 all patients and survival for patients with pancreatic head tumors were the primary end points.

50 A gastrin-producing islet cell tumor of the pancreatic head was also present.

51 The pancreatic head was involved in 74 patients (64%), follo

52 y resectable localized adenocarcinoma of the pancreatic head were entered onto a preoperative protoco

53 c pancreatitis with inflammatory mass in the pancreatic head were randomly assigned in 2 treatment gr

54 x patients with ductal adenocarcinoma of the pancreatic head were treated by regional subtotal or tot

55 Local resection of the pancreatic head, with or without duct drainage, and duod